Medicine & Life Sciences
AIC246
22%
Anti-Bacterial Agents
17%
Antiviral Agents
24%
Bacteremia
6%
Bacterial Infections
8%
Carbapenem-Resistant Enterobacteriaceae
8%
carbapenemase
5%
Carbapenems
8%
Cell Culture Techniques
5%
Chlamydia
5%
Cidofovir
12%
Clinical Trials
8%
Codon
13%
Communicable Diseases
13%
Coronavirus
18%
Coronavirus Infections
5%
cyclopropavir
7%
Cytomegalovirus
100%
Cytomegalovirus Infections
27%
dalbavancin
6%
Delivery of Health Care
14%
DNA
5%
DNA-Directed DNA Polymerase
15%
Drug Resistance
20%
Epidemiology
6%
Exonucleases
7%
Fluoroquinolones
5%
Foscarnet
20%
Ganciclovir
40%
Genes
8%
Gonorrhea
7%
Guidelines
6%
Hematologic Neoplasms
14%
Hematopoietic Stem Cell Transplantation
7%
Hematopoietic Stem Cells
10%
Hepacivirus
6%
Hepatitis C
5%
High-Throughput Nucleotide Sequencing
5%
HIV
22%
In Vitro Techniques
7%
Incidence
9%
Infection Control
5%
Infections
38%
Inpatients
5%
Invasive Fungal Infections
6%
isavuconazole
6%
maribavir
50%
Meropenem
6%
Methicillin-Resistant Staphylococcus aureus
17%
methylenecyclopropane
5%
Mutation
35%
Mycobacterium abscessus
7%
Neurocysticercosis
8%
Nontuberculous Mycobacteria
10%
Nursing Homes
5%
Organ Transplantation
8%
Osteomyelitis
5%
Outpatients
11%
Pandemics
7%
Pharmaceutical Preparations
20%
Phenotype
5%
Phosphotransferases
24%
Population
8%
Pre-Exposure Prophylaxis
12%
Pseudomonas aeruginosa
7%
Pseudomonas Infections
7%
Public Health
5%
Quinolones
10%
Respiratory Tract Infections
5%
Rifampin
5%
Safety
5%
SARS Virus
8%
Severe Acute Respiratory Syndrome
6%
Sexual and Gender Minorities
6%
Skin
5%
Staphylococcal Infections
13%
Staphylococcus aureus
6%
Substance-Related Disorders
5%
Suppuration
5%
Tenofovir
8%
terminase
10%
Therapeutics
16%
Tissue Donors
7%
Toxoplasma
8%
Toxoplasmosis
9%
Transplant Recipients
36%
Transplants
23%
Tuberculosis
9%
United States Department of Veterans Affairs
14%
Vaccination
9%
Vaccines
10%
Valganciclovir
7%
Vancomycin
5%
Veterans
18%
Veterans Health
14%
Viral Drug Resistance
12%
Viral Load
6%
Virus Diseases
5%
Viruses
13%